Skip to main content
. 2023 Aug 9;15(16):4028. doi: 10.3390/cancers15164028

Figure 3.

Figure 3

Kaplan–Meier curves of CAR T cell-treated patients. (A) Kaplan–Meier curve for PFS, regardless CAR T cells type; (B) Kaplan–Meier curve for OS irrespective of CAR T cell type; (C) Kaplan–Meier curve for PFS depending on CAR T cell type (tisagenlecleucel versus axicabtagen ciloleucel); and (D) Kaplan–Meier curve for OS depending on CAR T cell type (tisagenlecleucel versus axicabtagen ciloleucel). Axi-cel: axicabtagene ciloleucel; CAR T cells: chimeric antigen receptor T cells; DLBCL: diffuse large B-cell lymphoma; OS: overall survival; PFS: progression-free survival; tisa-cel: tisagenlecleucel.